# Matt Wilson

> Dr Matt Wilson is the founder and CEO of uMed, a research technology company that helps healthcare providers identify, contact and enroll suitable patients in studies while linking consented information from health records and remote data collection. A former emergency doctor, anaesthetist and Royal Marines medical officer, Wilson turned first-hand frustration with clinicians' lack of time into a company designed to make research part of routine care rather than an extra administrative project.

- **Role:** Founder & Chief Executive Officer at uMed
- **Organizations:** uMed, NHS England, Royal Navy, Royal Marines, University Hospitals Plymouth NHS Trust, Ampersand & Ampersand
- **Education:** MB BCh, Honours Classification, Cardiff University / Prifysgol Caerdydd
- **Known for:** Founded and scaled uMed from an early, non-scalable concept into a funded clinical research technology company., Secured uMed's first GP federation partnership, which Wilson has described as his proudest early company milestone., Led uMed through a £3.7 million seed round in 2020 and a £9.8 million Series A in 2023.

## Career timeline

- **2009** — Received an MB BCh Honours Classification from Cardiff University.
- **Early career** — Worked in NHS emergency medicine and anaesthesia, including at University Hospitals Plymouth NHS Trust.
- **Early career** — Served as a Royal Navy medical officer supporting the Royal Marines.
- **Pre-2018** — Worked as Chief Medical Officer at Ampersand & Ampersand and participated in the NHS England Clinical Entrepreneur programme.
- **2018** — Founded uMed to make clinical research easier to run through routine healthcare settings.
- **2019** — Playfair Capital invested in uMed; Wilson publicly described the first, unsuccessful version of the business and the lessons carried forward.
- **2020** — uMed raised a £3.7 million seed round to expand its platform and US presence.
- **2021** — Returned to clinical practice to support a local intensive care unit during the first pandemic wave, while continuing to lead uMed.
- **2023** — uMed raised a £9.8 million Series A from Delin Ventures, AlbionVC, Playfair Capital and 11.2 Capital.
- **2025** — Discussed uMed's US growth, hiring and relationship-led business development on the How I'm Building This podcast.
- **2026** — Continued leading uMed from Greater Boston and publishing commentary on clinical research infrastructure.

## Achievements

- Founded and scaled uMed from an early, non-scalable concept into a funded clinical research technology company.
- Secured uMed's first GP federation partnership, which Wilson has described as his proudest early company milestone.
- Led uMed through a £3.7 million seed round in 2020 and a £9.8 million Series A in 2023.
- By July 2023, uMed reported more than 450 UK GP practices representing five million patients and more than 6,000 patients recruited to studies.
- Built uMed's expansion strategy across the UK and North America.
- Served as an NHS physician and a Royal Navy medical officer supporting the Royal Marines before becoming a full-time founder.

## Latest updates

- **2026-05** — Published a LinkedIn article titled 'The Site Problem Nobody in Pharma Wants to Name' about power and incentives in clinical research sites.
- **2026-04** — Appeared at Impatient Health's Pharmageddon conference to discuss consented communities and reducing barriers to evidence generation.
- **2025-07** — Joined the How I'm Building This podcast to discuss uMed's growth, hiring, US relationships, competitive positioning and ambassador-led business development.
- **2024-09** — Appeared on The Healthtech Podcast for a discussion about data collection, data sharing and uMed's research model.
- **2023-07** — Announced uMed's £9.8 million Series A to expand trial participation and North American operations.

## Links

- Website: https://www.umed.io
- LinkedIn: https://www.linkedin.com/in/drmattwilson
- Twitter/X: https://twitter.com/umed_io

---

Profile page: https://yespress.io/matt-wilson
Published by YesPress — https://yespress.io
Last updated: 2026-08-26